DrugPatentWatch Database Preview
Patent: 7,459,435
» See Plans and Pricing
Summary for Patent: 7,459,435
| Title: | Treatment of disturbances of iron distribution |
| Abstract: | A method of, and pharmaceutical composition for, treating disturbances of iron distribution in diabetes using erythropoietin are disclosed. |
| Inventor(s): | Lehmann; Paul (Worms, DE), Roeddiger; Ralf (Gorxheimertal, DE), Walter-Matsui; Ruth (Altenbuseck, DE) |
| Assignee: | Hoffmann-La Roche Inc. (Nutley, NJ) |
| Application Number: | 10/634,477 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,459,435
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | Start Trial | Hoffmann-La Roche Inc. (Nutley, NJ) | 2022-08-29 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 009 | 2001-09-17 | Start Trial | Hoffmann-La Roche Inc. (Nutley, NJ) | 2022-08-29 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 008 | 2001-09-17 | Start Trial | Hoffmann-La Roche Inc. (Nutley, NJ) | 2022-08-29 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 007 | 2001-09-17 | Start Trial | Hoffmann-La Roche Inc. (Nutley, NJ) | 2022-08-29 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 006 | 2001-09-17 | Start Trial | Hoffmann-La Roche Inc. (Nutley, NJ) | 2022-08-29 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 7,459,435
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2004019972 | Start Trial |
| United States of America | 2004110679 | Start Trial |
| Russian Federation | 2005108976 | Start Trial |
| Russian Federation | 2305554 | Start Trial |
| Poland | 209699 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
